Grampus Pharmaceuticals Private Limited
About Grampus Pharmaceuticals Private Limited
Data last updated:
Grampus Pharmaceuticals Private Limited is a private limited company based in Ambala, Haryana, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 05 March 2001 and has been in existence for over 25 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24231HR2001PTC034631.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹7.5 Lakh. It is led by directors Pawan Kumar Maini (Managing Director) and Manav Maini.
Its last annual general meeting (AGM) was held on 04 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 14 Bank Colonyambala City, Haryana, India – 134003.
As per the financials filed for FY 2025, the company reported a revenue of ₹36.17 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹58,100 (net margin 1.6%) and EBITDA of ₹96,400 (EBITDA margin 2.7%). Revenue has grown at a compounded annual rate (CAGR) of 156% over three years and 66% over five years.
As per MCA filings, the company has satisfied charges of ₹28 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Grampus Pharmaceuticals Private Limited's registered office is in Ambala, Haryana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address14 Bank Colonyambala City, Haryana, India – 134003
- IndustryTrading, Wholesale, Other Wholesale
To see the full contact details of Grampus Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Grampus Pharmaceuticals Private Limited
FY 2025 filings availableGrampus Pharmaceuticals Private Limited reported revenue of ₹36.17 Lakh (up 452% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 66% over five years, including 452% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹96,400 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹58,100 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.7% | ||||
| Net Profit Margin | 1.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Grampus Pharmaceuticals Private Limited, buy the company report.
Board of directors of Grampus Pharmaceuticals Private Limited
Grampus Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manav Maini | Director | 17 Nov 2008 | 17 Years 11 Months | Current |
| Pawan Kumar Maini | Managing Director | 05 Mar 2001 | 25 Years 7 Months | Current |
Auditor
Grampus Pharmaceuticals Private Limited is audited by GOEL SUBHASH AND ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GOEL SUBHASH AND ASSOCIATES | FY 2017 | 08295N |
Shareholding
The shareholding of Grampus Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Grampus Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Oct 2008 | 10130881 | State Bank of India | ₹3 Lakh | Satisfied | |
| 04 Jan 2008 | 10085021 | State Bank of India | ₹2 Lakh | Satisfied | |
| 30 Jun 2007 | 10086676 | State Bank of India | ₹3 Lakh | Satisfied | |
| 23 Dec 2004 | 90369547 | State Bank of India | ₹20 Lakh | Satisfied |
To see the full charge records of Grampus Pharmaceuticals Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
No court or tribunal cases involving Grampus Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Grampus Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Grampus Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Grampus Pharmaceuticals Private Limited has 3 board changes on record since 2001: 2 appointments and 1 cessation. The latest: Puneet Kumar Batra ceased to be Director on 28 Nov 2024.
3 earlier events are in the company report.
Frequently asked questions
Grampus Pharmaceuticals is an active private limited company based in Ambala, Haryana, India. The company works in wholesale, within the trading industry. It was incorporated on 05 March 2001 (25+ years old) and is registered under CIN U24231HR2001PTC034631.
Grampus Pharmaceuticals has 2 current directors:
- Pawan Kumar Maini - Managing Director
- Manav Maini - Director
The latest financial statements of Grampus Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 04 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Grampus Pharmaceuticals is U24231HR2001PTC034631. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Grampus Pharmaceuticals was incorporated on 05 March 2001, making it 25+ years old. It is registered with the Registrar of Companies, Haryana.
Puneet Kumar Batra ceased to be Director on 28 Nov 2024. Manav Maini was appointed as Director on 17 Nov 2008. Pawan Kumar Maini was appointed as Managing Director on 05 Mar 2001.
The registered office of Grampus Pharmaceuticals is at 14 Bank Colonyambala City, Haryana, India – 134003.
Grampus Pharmaceuticals operates in the trading industry, in the wholesale segment.
Grampus Pharmaceuticals has no open charges and satisfied charges of ₹28 Lakh as per latest MCA filings.
The compliance status of Grampus Pharmaceuticals is compliant as of 25 July 2026. The company is actively filing with the Registrar of Companies.